Quantexa Launches New Asia Pacific Headquarters in Singapore to Capture Next Wave of Growth
Globe Newswire7-11-2023, 17:20
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers 17-06-2024, 17:00
